Harro, C D <br/><br/>
Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine.  [electronic resource] 

 -  Journal of the National Cancer Institute  Feb 2001 
 - 284-92 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0027-8874 
<br/><br/><label>Standard No.: </label>10.1093/jnci/93.4.284  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--administration & dosage<br/>Adult<br/>Alum Compounds--administration & dosage<br/>Antibodies, Viral--blood<br/>Baculoviridae<br/>Double-Blind Method<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Humans<br/>Immunization Schedule<br/>Immunoglobulins--blood<br/>Injections, Intramuscular<br/>Male<br/>Papillomaviridae--immunology<br/>Papillomavirus Vaccines<br/>Polysorbates--administration & dosage<br/>Recombinant Proteins<br/>Reference Values<br/>Squalene--administration & dosage<br/>Viral Vaccines--administration & dosage